Evidence map›Paper›PMID 37018352›Full record

ArticlePloS one2023

Distinctive features of lipoprotein profiles in stroke patients.

Tomokazu Konishi, Yurie Hayashi, Risako Fujiwara, Shinpei Kawata, Tatsuya Ishikawa

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Tomokazu KonishiGraduate School of Bioresource Sciences, Akita Prefectural University, Akita, Japan.ORCID 0000-0003-4826-6265
Yurie HayashiGraduate School of Bioresource Sciences, Akita Prefectural University, Akita, Japan.
Risako FujiwaraCardiovascular Internal Medicine, Akita City Hospital, Akita, Japan.
Shinpei KawataResearch Institute of Akita Cerebrospinal and Cardiovascular Center, Akita Prefectural Hospital Organization, Akita, Japan.
Tatsuya IshikawaResearch Institute of Akita Cerebrospinal and Cardiovascular Center, Akita Prefectural Hospital Organization, Akita, Japan.
Akita Prefectural University · JPAkita University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Classes of lipoproteins solubilize lipids in the blood, and their profiles are important for preventing atherosclerotic diseases. These can be identified by gel filtration HPLC, which has been analyzed in a manner that yields the same values as the de facto standard method, i.e., ultracentrifugation; however, previous studies have found that ultracentrifugation and its simplified alternatives, enzymatic methods, yield incorrect values. Here HPLC data of stroke patients and the controls were compared using data-driven analyses, without consideration for ultracentrifugation. The data well-separated patients from controls. In many patients, the level of HDL1 (a cholesterol scavenger) was low. The TG/cholesterol ratio of chylomicrons was found to be low in patients and high in the healthy elderly; the lower level may indicate a larger intake of animal fats. High levels of free glycerol in the elderly were hazardous, suggesting more dependence on lipids as an energy source. Statins had minimal effect on these factors. LDL cholesterol, the commonly-used risk indicator, was not a risk factor actually. Enzymatic methods failed to separate the patients from the control; hence, the existing guidelines for screening methods and medical treatment need to be revised. As an immediate step, glycerol would be an adaptable indicator.

Indexed as

GlycerolStrokeAnimalsCholesterolCholesterol, HDLChylomicronsLipoproteinsLipoproteins, LDLTriglyceridesUltracentrifugationCholesterolCholesterol, HDLChylomicronsGlycerolLipoproteinsLipoproteins, LDLTriglycerides

Identifiers

PMID37018352
PMCPMC10075468
OpenAlexW4362601346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.